HollyTM Implantable Continuous Dialysis System Could be Ready for Human Trials Soon

The device, granted FDA breakthrough status last December, may be ready for human testing in 20-24 months. Besides being a bridge to transplant, it can improve quality of life for those who do not qualify for a transplant.

Read the full article » | Posted 04-14-2026

Related Articles

• Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
• New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026
• Emerging Biomarker Research in PD Posted 03-12-2026
• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026